| RESMED INC. DL-,004 |
| USA |
| Gesundheit |
| US7611521078 / 895878 |
| RME (Frankfurt) / RMD (NYSE) |
| FRA:RME, ETR:RME, RME:GR, NYSE:RMD |
| S&P500 |
| https://investor.resmed.c.. |
|
ResMed Inc. is a healthcare company that develops and supplies digital health technologies and cloud-connected medical devices for respiratory care. Its core products support the treatment of sleep apnea, COPD, and other chronic diseases through flow..
>Volltext.. |
| 23710.33 Mio. EUR |
| 22998.64 Mio. EUR |
| 4749.88 Mio. EUR |
| 1876.9 Mio. EUR |
| 1303.36 Mio. EUR |
| 8.93 EUR |
| 723.2 Mio. EUR |
| 1424.26 Mio. EUR |
| - |
| 1.23 |
| 3.26% |
| 8.35% |
| 2.05 EUR |
| 1.22% |
| 1.2% |
| 14.05.26 - 0.51204€ 12.02.26 - 0.50544006€ >weitere anzeigen... |
| RESMED |
| 01.06.26 |
|
||||
|
||||
|